J
Jane M. Andrews
Researcher at Royal Adelaide Hospital
Publications - 329
Citations - 14638
Jane M. Andrews is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 48, co-authored 298 publications receiving 12270 citations. Previous affiliations of Jane M. Andrews include St. Vincent's Health System & Health Science University.
Papers
More filters
Journal ArticleDOI
Nutrient-induced spatial patterning of human duodenal motor function
Jane M. Andrews,Selena Doran,Geoffrey S. Hebbard,Charles H. Malbert,Michael Horowitz,John Dent +5 more
TL;DR: The spatiotemporal patterning of duodenal motor function has been evaluated comprehensively for the first time in humans, with a novel 21-lumen manometric assembly, and substantial variability in response to different nutrient delivery rates is shown.
Journal ArticleDOI
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
James D. Doecke,Felicity Hartnell,P. Bampton,Sally Bell,Gillian Mahy,Zubin Grover,Peter Lewindon,Lee W. Jones,Karen Sewell,Krupa Krishnaprasad,Ruth Prosser,D. Marr,Jesse Fischer,Gareth R. Thomas,Jane V. Tehan,Nik S. Ding,Sharon E. Cooke,K. Moss,Alexandra Sechi,P. De Cruz,Rachel Grafton,Susan J. Connor,I.C. Lawrance,Richard B. Gearry,Jane M. Andrews,Graham L. Radford-Smith +25 more
TL;DR: Maintenance anti‐tumour necrosis factor‐α (anti‐TNFα) treatment for Crohn's disease is the standard of care for patients with an inadequate response to corticosteroids and immunomodulators.
Journal ArticleDOI
An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation
Antonina Mikocka-Walus,Antonina Mikocka-Walus,Deborah Turnbull,Gerald Holtmann,Gerald Holtmann,Jane M. Andrews,Jane M. Andrews +6 more
TL;DR: The data to date suggest that an integrated model of care for patients with IBD may yield superior long‐term outcomes in terms of medication use and hospitalization rates and reduce healthcare costs.
Journal ArticleDOI
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Antonina Mikocka-Walus,Andrea Fielder,Stephanie L. Prady,Adrian Esterman,Simon R. Knowles,Jane M. Andrews +5 more
TL;DR: The efficacy and safety of antidepressants for treating anxiety and depression in IBD, and the effects of antidepressants on quality of life (QoL) and managing disease activity in I BD are assessed.
Journal ArticleDOI
Genetic susceptibility in IBD: Overlap between ulcerative colitis and Crohn's disease
James D. Doecke,Lisa A. Simms,Zhen Zhen Zhao,Ning Huang,Katherine Hanigan,Krupa Krishnaprasad,Krupa Krishnaprasad,Rebecca L. Roberts,Jane M. Andrews,Gillian Mahy,Peter A. Bampton,Peter Lewindon,Peter Lewindon,Timothy H. Florin,Timothy H. Florin,Ian C. Lawrance,Richard B. Gearry,Grant W. Montgomery,Graham L. Radford-Smith,Graham L. Radford-Smith,Graham L. Radford-Smith +20 more
TL;DR: Of the 29 SNPs conferring high genetic susceptibility to CD, 28 were not associated with UC, thus indicating that for this SNP set there is a low level of overlap between the two major forms of IBD.